One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly occurent cancer types in 2012 and have high reoccurrence rate as well. The risk of acquiring bladder cancer is high among smokers, aging population, workers at chemical industry, and among people with urinary tract infections. Timely diagnosis of Urinary tract cancers help design efficient treatment approaches aimed at eliminating the disease. As per few research studies it has been identified that around 75% to 80% of the cancer patients survive if it is diagnosed in the early stages. The major factors favoring the growth of the urinary tract cancer treatment market are increasing incidence of urinary tract cancer worldwide owing to rising sedentary lifestyle, geriatric population, rising smoking population and rigorous research activities towards developing urinary tract cancer therapeutics. Clinical trial review of the therapeutics to treat urinary tract cancer seems to provide a lucrative growth prospects for this market.
The global urinary tract cancer market is segmented on the basis of types, diagnostic techniques, treatment procedures and geography. On the basis of types urinary tract cancer market is further categorized into Urothelial carcinoma, Squamous cell carcinoma, Adenocarcinoma and others. Among the urinary tract cancer types, urothelial carcinoma is the most-prevalent with ~90% to 95% occurrence rate, globally. Based on diagnostic techniques it is segmented into Cystoscopy, Urine analyses, Transurethral resection of tumor and Imaging tests. Being a part of initial evaluation in diagnosis of any urinary tract cancer, cytoscopy is the most important investigation for bladder cancer. Segmentation on the basis of treatment procedures categorizes the market into Surgery, Intravesical therapy, Chemotherapy, and Radiation therapy. Geographically, the global urinary tract cancer market is segmented into North America, Europe, Asia-Pacific and LAMEA. Factors such as higher occurrence rate of urinary tract cancer, higher healthcare spending, availability of advanced healthcare services & technology, reimbursement coverage and relatively higher rate of awareness are driving the growth of the urinary tract cancer market in North America and Europe.
Some key market players are Spectrum pharmaceuticals Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Genzyme Corporation, F. Hoffmann-La Roche Ltd., Shionogi & Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Medical Enzymes AG, IkerChem S.L., and Amgen Inc.
KEY MARKET SEGMENTS
The global urinary tract cancer market is segmented into four categories: types, diagnostic techniques, treatment and geography.
MARKET BY TYPES
MARKET BY DIAGNOSTIC TECHNIQUES
MARKET BY TREATMENT PROCEDURES
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
The Human Micobiome market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include many company. With key sales data like sales (volume), revenue, market ...
March 2017 | $3360 | View Details >>
Summary Concordia Healthcare Corp. (Concordia), formerly Mercari Acquisition Corp. is a pharmaceutical company that offers orphan drugs. The company undertakes the management and acquisition of legacy pharmaceutical products, orphan drugs and medical devices for diabetics. Its product portfolio comprises Orapred, Donnatal, Ulesfia, Zonegran, Dibenzyline, Dutoprol, Dyrenium, Fortaz, Kayexalate, Lanoxin, Parnate, Nilandron, ...
April 2016 | $250 | View Details >>
Notes: Production, means the output of Measle Vaccine Revenue, means the sales value of Measle Vaccine This report studies Measle Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, ...
February 2017 | $2900 | View Details >>
The Europe Antacid Tablet Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Antacid Tablet industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the ...
March 2017 | $3800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research